NCT03986515 2019-06-14Apatinib Plus SHR1210 in Advanced Mucosal MelanomaHenan Cancer HospitalPhase 2 Unknown40 enrolled
NCT03383237 2017-12-27Clinical Study of Apatinib as the Second-line Therapy in Malignant MelanomaHenan Cancer HospitalPhase 2 Unknown20 enrolled